Fundz

Who to call at Pierre Fabre Laboratories, and when

Fundz watches for the moments Pierre Fabre Laboratories starts buying, and tells you who to reach.

  • An alert the day Pierre Fabre Laboratories raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pierre Fabre Laboratories, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pierre Fabre Laboratories. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Laboratoires Pierre Fabre Partners with XtalPi for AI-Driven Drug Discovery in Oncology and Rare Diseases.

Nov 09, 2026

Contract Type

partnership

ManufacturingBiotechnologyHealth Carepharmaceuticals

Description

Laboratoires Pierre Fabre and XtalPi have entered an agreement to collaborate on the discovery of novel clinical candidates using AI technology. The partnership aims to enhance drug discovery capabilities by integrating XtalPi's AI and robotics with Laboratoires Pierre Fabre's expertise.

Quick answer

Laboratoires Pierre Fabre Partners with XtalPi for AI-Driven Drug Discovery in Oncology and Rare Diseases. (November 9, 2026).

What agreement did Pierre Fabre Laboratories announce on November 9, 2026?
Laboratoires Pierre Fabre and XtalPi have entered an agreement to collaborate on the discovery of novel clinical candidates using AI technology. The partnership aims to enhance drug discovery capabilities by integrating XtalPi's AI and robotics with Laboratoires Pierre Fabre's expertise.
What does Pierre Fabre Laboratories do?
Pierre Fabre Laboratories is a leading French medical and beauty care company with over 4 decades of experience in innovation, development, manufacturing, and commercialization in oncology.
Which similar companies announced agreements around the same time?
CGBIO (November 9, 2026), Medtronic plc (November 7, 2026), Abbott Laboratories (November 5, 2026) and Sino Biopharmaceutical (November 13, 2026) also announced agreements within 45 days of Pierre Fabre Laboratories.

Source: Fundz verified event record.

Other recent agreements in pharmaceuticals and Manufacturing

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

Pierre Fabre Laboratories

Location

3 Avenue Hubert Curien

About

Pierre Fabre Laboratories is a leading French medical and beauty care company with over 4 decades of experience in innovation, development, manufacturing, and commercialization in oncology. The company dedicated about 80% of its R&D spendings to oncology in 2022 and has declared targeted therapies as its main R&D priority. Its current commercial portfolio in oncology covers colorectal, breast and lung cancers, melanoma, hematology, and pre-cancerous skin conditions like actinic keratosis. In 2022, Pierre Fabre Laboratories posted 2.7 billion euros in revenues, 69% of which came from international sales in 120 countries. Established in the South-West of France since its creation in 1962, the Group manufactures over 90% of its products in France and employs some 9,600 people worldwide. The company is 86%-owned by the Pierre Fabre Foundation, a government-recognized public-interest foundation, and secondarily by its own employees through an international employee stock ownership plan. Pierre Fabre Laboratories' sustainability policy has been assessed by the independent AFNOR Certification body at the "Exemplary" level of its CSR label (ISO 26 000 standard for sustainable development). Further information about Pierre Fabre Laboratories can be found at www.pierre-fabre.com, @PierreFabre.

Predictive Intelligence
Strategic

ML-powered predictions for Pierre Fabre Laboratories's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Pierre Fabre Laboratories signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.